Clinical trial
SOLX Gold Shunt for Refractory Glaucoma
NCT01282346 · SOLX, Inc., Industry · Completed
Key facts
| NCT number | NCT01282346 |
|---|---|
| Title | SOLX Gold Shunt for Refractory Glaucoma |
| Official title | Clinical Evaluation of the SOLX Gold Shunt for the Reduction of Intraocular Pressure (IOP) in Refractory Glaucoma |
| Lead sponsor | SOLX, Inc., Industry |
| Status | Completed |
| Study type | Interventional |
| Conditions | Glaucoma, Open Angle |
| Intervention type | Device |
| Interventions | SOLX Gold Shunt |
| Enrollment | 116 |
| Start date | Jan 1, 2011 |
| Primary completion | Dec 1, 2015 |
| Completion | Dec 1, 2015 |
| First posted | Jan 25, 2011 |
| Last update posted | Feb 23, 2017 |
| Countries | Brazil, Canada, Israel, United States, Venezuela |
At a glance
- 10–99 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: